Christoph Franz, Roche chairman
Roche chairman Christoph Franz offers glint of hope after tiragolumab fail — report
On the heels of a bad week for Roche and its TIGIT tiragolumab, board chair Christoph Franz is trying to look on the bright side …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
